1. Home
  2. GAIA vs KLRS Comparison

GAIA vs KLRS Comparison

Compare GAIA & KLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAIA
  • KLRS
  • Stock Information
  • Founded
  • GAIA 1988
  • KLRS 2019
  • Country
  • GAIA United States
  • KLRS United States
  • Employees
  • GAIA N/A
  • KLRS N/A
  • Industry
  • GAIA Movies/Entertainment
  • KLRS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GAIA Consumer Discretionary
  • KLRS Health Care
  • Exchange
  • GAIA Nasdaq
  • KLRS Nasdaq
  • Market Cap
  • GAIA 110.5M
  • KLRS 129.0M
  • IPO Year
  • GAIA 1999
  • KLRS N/A
  • Fundamental
  • Price
  • GAIA $4.91
  • KLRS $3.30
  • Analyst Decision
  • GAIA Strong Buy
  • KLRS Buy
  • Analyst Count
  • GAIA 2
  • KLRS 1
  • Target Price
  • GAIA $8.00
  • KLRS N/A
  • AVG Volume (30 Days)
  • GAIA 52.2K
  • KLRS 49.7K
  • Earning Date
  • GAIA 05-12-2025
  • KLRS 05-14-2025
  • Dividend Yield
  • GAIA N/A
  • KLRS N/A
  • EPS Growth
  • GAIA N/A
  • KLRS N/A
  • EPS
  • GAIA N/A
  • KLRS N/A
  • Revenue
  • GAIA $92,889,000.00
  • KLRS N/A
  • Revenue This Year
  • GAIA $13.93
  • KLRS N/A
  • Revenue Next Year
  • GAIA $15.16
  • KLRS N/A
  • P/E Ratio
  • GAIA N/A
  • KLRS N/A
  • Revenue Growth
  • GAIA 13.15
  • KLRS N/A
  • 52 Week Low
  • GAIA $2.93
  • KLRS $2.65
  • 52 Week High
  • GAIA $6.53
  • KLRS $24.15
  • Technical
  • Relative Strength Index (RSI)
  • GAIA 53.15
  • KLRS N/A
  • Support Level
  • GAIA $4.25
  • KLRS N/A
  • Resistance Level
  • GAIA $5.37
  • KLRS N/A
  • Average True Range (ATR)
  • GAIA 0.28
  • KLRS 0.00
  • MACD
  • GAIA 0.02
  • KLRS 0.00
  • Stochastic Oscillator
  • GAIA 58.93
  • KLRS 0.00

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

About KLRS Kalaris Therapeutics Inc. Common Stock

Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.

Share on Social Networks: